Warsaw, Ind.-based WishBone said in a news release that Vizient’s membership base includes more than 50% of the nation’s acute care providers, allowing WishBone’s “Just-In-Time” supply of single-use sterile kits for children with orthopedic issues to give healthcare facilities options for immediate availability and shipment at contracted prices as needed.
“In the year 2020, there is still a huge technology deficit in the OR with 95% of children receiving adult implants not cleared by the FDA for pediatric use,” WishBone founder & CEO Nick Deeter said in the release. “In some instances, these off-label applications can cause more harm than good. WishBone is thrilled about another game-changing opportunity to create greater access to solutions that are truly designed around the unmet needs of kids.”
“As surgeons take on a surge of cases post-COVID-19 pandemic, the need for single-use, sterile packed procedure kits has become increasingly apparent,” WishBone chief revenue officer Kevin Blue added. “The timing of this partnership could not be more serendipitous.”